S1746 Rethinking the Role of IL-13 in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS) Colitis Induced Fibrosis
Xiaomei Sun(Niigata University), Mamoru Watanabe(The University of Tokyo), Takashi Nagaishi(Tokyo Medical and Dental University), Michio Onizawa(Fukushima Medical University), Yusuke Kawauchi, Kenji Suzuki(Iwate Medical University), Ren Xu(Xiamen University), Hana Yamaguchi, Shuang Wang(Dalian Medical University), Kenichi Watanabe, Masaki Nagata(National Medical Research Center of Dentistry and Maxillofacial Surgery), Masahiro Suzuki(National Hospital Organization), Hitoshi Asakura(Niigata University), Naoto Tsuge, Teruji Totsuka, Osamu Yamaji
Unknown
January 1, 2010
Cited by 0
Related Papers
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Evidence-based clinical practice guidelines for cholelithiasis 2016
|Journal of Gastroenterology|2016|262
Suppression of Hepatitis C Virus Replication by Cyclosporin A Is Mediated by Blockade of Cyclophilins
|Gastroenterology|2005|211
Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease
|The Journal of Experimental Medicine|2000|198
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial
|Journal of Gastroenterology|2002|194